Literature DB >> 27927967

The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele.

Seema Patel1, Steven M Blaauboer2, Heidi R Tucker2, Samira Mansouri1,2, Juan Sebastian Ruiz-Moreno3, Lutz Hamann3, Ralf R Schumann4, Bastian Opitz3, Lei Jin5,2.   

Abstract

TMEM173 encodes MPYS/STING and is an innate immune sensor for cyclic dinucleotides (CDNs) playing a critical role in infection, inflammation, and cancer. The R71H-G230A-R293Q (HAQ) of TMEM173 is the second most common human TMEM173 allele. In this study, using data from the 1000 Genomes Project we found that homozygous HAQ individuals account for ∼16.1% of East Asians and ∼2.8% of Europeans whereas Africans have no homozygous HAQ individuals. Using B cells from homozygous HAQ carriers, we found, surprisingly, that HAQ/HAQ carriers express extremely low MPYS protein and have a decreased TMEM173 transcript. Consequently, the HAQ/HAQ B cells do not respond to CDNs. We subsequently generated an HAQ knock-in mouse expressing a mouse equivalent of the HAQ allele (mHAQ). The mHAQ mouse has decreased MPYS protein in B cells, T cells, Ly6Chi monocytes, bone marrow-derived dendritic cells, and lung tissue. The mHAQ mouse also does not respond to CDNs in vitro and in vivo. Lastly, Pneumovax 23, with an efficacy that depends on TMEM173, is less effective in mHAQ mice than in wild type mice. We conclude that HAQ is a null TMEM173 allele. Our findings have a significant impact on research related to MPYS-mediated human diseases and medicine.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27927967      PMCID: PMC5225030          DOI: 10.4049/jimmunol.1601585

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.

Authors:  Juan Fu; David B Kanne; Meredith Leong; Laura Hix Glickman; Sarah M McWhirter; Edward Lemmens; Ken Mechette; Justin J Leong; Peter Lauer; Weiqun Liu; Kelsey E Sivick; Qi Zeng; Kevin C Soares; Lei Zheng; Daniel A Portnoy; Joshua J Woodward; Drew M Pardoll; Thomas W Dubensky; Young Kim
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

2.  The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation.

Authors:  Bo Zhong; Yan Yang; Shu Li; Yan-Yi Wang; Ying Li; Feici Diao; Caoqi Lei; Xiao He; Lu Zhang; Po Tien; Hong-Bing Shu
Journal:  Immunity       Date:  2008-09-25       Impact factor: 31.745

3.  Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1.

Authors:  Takayuki Abe; Glen N Barber
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

4.  STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice.

Authors:  Zili Wang; Esteban Celis
Journal:  Cancer Immunol Immunother       Date:  2015-05-19       Impact factor: 6.968

5.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity.

Authors:  Hiroki Ishikawa; Zhe Ma; Glen N Barber
Journal:  Nature       Date:  2009-09-23       Impact factor: 49.962

6.  Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).

Authors:  S Tsuchiya; M Yamabe; Y Yamaguchi; Y Kobayashi; T Konno; K Tada
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

7.  Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA.

Authors:  Pu Gao; Manuel Ascano; Thomas Zillinger; Weiyi Wang; Peihong Dai; Artem A Serganov; Barbara L Gaffney; Stewart Shuman; Roger A Jones; Liang Deng; Gunther Hartmann; Winfried Barchet; Thomas Tuschl; Dinshaw J Patel
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

8.  STING manifests self DNA-dependent inflammatory disease.

Authors:  Jeonghyun Ahn; Delia Gutman; Shinobu Saijo; Glen N Barber
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-06       Impact factor: 11.205

9.  The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo.

Authors:  Steven M Blaauboer; Samira Mansouri; Heidi R Tucker; Hatti L Wang; Vincent D Gabrielle; Lei Jin
Journal:  Elife       Date:  2015-04-21       Impact factor: 8.140

10.  Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses.

Authors:  Christian K Holm; Stine H Rahbek; Hans Henrik Gad; Rasmus O Bak; Martin R Jakobsen; Zhaozaho Jiang; Anne Louise Hansen; Simon K Jensen; Chenglong Sun; Martin K Thomsen; Anders Laustsen; Camilla G Nielsen; Kasper Severinsen; Yingluo Xiong; Dara L Burdette; Veit Hornung; Robert Jan Lebbink; Mogens Duch; Katherine A Fitzgerald; Shervin Bahrami; Jakob Giehm Mikkelsen; Rune Hartmann; Søren R Paludan
Journal:  Nat Commun       Date:  2016-02-19       Impact factor: 14.919

View more
  24 in total

1.  Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.

Authors:  Clayton M Carey; Apurva A Govande; Juliane M Cooper; Melissa K Hartley; Philip J Kranzusch; Nels C Elde
Journal:  Cell Host Microbe       Date:  2019-01-31       Impact factor: 21.023

2.  Response to Comment on "The Common R71H-G230A-R293Q Human TMEM173 Is a Null Allele".

Authors:  Seema Patel; Steven M Blaauboer; Heidi R Tucker; Samira Mansouri; Juan Sebastian Ruiz-Moreno; Lutz Hamann; Ralf R Schumann; Bastian Opitz; Lei Jin
Journal:  J Immunol       Date:  2017-06-01       Impact factor: 5.422

3.  STING differentially regulates experimental GVHD mediated by CD8 versus CD4 T cell subsets.

Authors:  Cameron S Bader; Henry Barreras; Casey O Lightbourn; Sabrina N Copsel; Dietlinde Wolf; Jingjing Meng; Jeonghyun Ahn; Krishna V Komanduri; Bruce R Blazar; Lei Jin; Glen N Barber; Sabita Roy; Robert B Levy
Journal:  Sci Transl Med       Date:  2020-07-15       Impact factor: 17.956

4.  The cGAS/STING Pathway Detects Streptococcus pneumoniae but Appears Dispensable for Antipneumococcal Defense in Mice and Humans.

Authors:  Juan Sebastian Ruiz-Moreno; Lutz Hamann; Lei Jin; Leif E Sander; Monika Puzianowska-Kuznicka; John Cambier; Martin Witzenrath; Ralf R Schumann; Norbert Suttorp; Bastian Opitz
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 5.  The STING pathway: Therapeutic vulnerabilities in ovarian cancer.

Authors:  Noor Shakfa; Deyang Li; Sarah Nersesian; Juliette Wilson-Sanchez; Madhuri Koti
Journal:  Br J Cancer       Date:  2022-04-05       Impact factor: 9.075

6.  B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses.

Authors:  Melissa M Walker; Bergren W Crute; John C Cambier; Andrew Getahun
Journal:  J Immunol       Date:  2018-10-03       Impact factor: 5.422

Review 7.  B cell MHC class II signaling: A story of life and death.

Authors:  Divya Sai Katikaneni; Lei Jin
Journal:  Hum Immunol       Date:  2018-04-30       Impact factor: 2.850

8.  In vitro STING Activation with the cGAMP-STINGΔTM Signaling Complex.

Authors:  Yanpu He; Celestine Hong; Darrell J Irvine; Jiahe Li; Paula T Hammond
Journal:  Bio Protoc       Date:  2021-02-05

9.  Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway.

Authors:  Bryan Gall; Kara Pryke; Jinu Abraham; Nobuyo Mizuno; Sara Botto; Tina M Sali; Rebecca Broeckel; Nicole Haese; Aaron Nilsen; Andrew Placzek; Thomas Morrison; Mark Heise; Daniel Streblow; Victor DeFilippis
Journal:  J Virol       Date:  2018-02-26       Impact factor: 6.549

Review 10.  STING and transplantation: can targeting this pathway improve outcomes?

Authors:  Cameron S Bader; Lei Jin; Robert B Levy
Journal:  Blood       Date:  2021-04-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.